Balyasny Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.4M | Buy |
424,578
+421,291
| +12,817% | +$38.7M | 0.05% | 427 |
|
|
2025
Q4 | $296K | Buy |
+3,287
| New | +$312K | ﹤0.01% | 2732 |
|
|
2025
Q2 | – | Sell |
-207,204
| Closed | -$23.5M | – | 3450 |
|
|
2025
Q1 | $23.5M | Buy |
+207,204
| New | +$22.2M | 0.04% | 535 |
|
|
2024
Q4 | – | Sell |
-19,671
| Closed | -$2.12M | – | 3343 |
|
|
2024
Q3 | $2.12M | Buy |
19,671
+14,900
| +312% | +$1.63M | ﹤0.01% | 1643 |
|
|
2024
Q2 | $518K | Buy |
+4,771
| New | +$562K | ﹤0.01% | 2044 |
|
|
2024
Q1 | – | Sell |
-199,536
| Closed | -$24.3M | – | 3197 |
|
|
2023
Q4 | $24.3M | Sell |
199,536
-750,331
| -79% | -$83.7M | 0.05% | 529 |
|
|
2023
Q3 | $107M | Buy |
949,867
+708,342
| +293% | +$90M | 0.22% | 93 |
|
|
2023
Q2 | $35.2M | Sell |
241,525
-104,369
| -30% | -$14.2M | 0.08% | 352 |
|
|
2023
Q1 | $44.7M | Sell |
345,894
-88,571
| -20% | -$11.1M | 0.11% | 251 |
|
|
2022
Q4 | $55.4M | Sell |
434,465
-748,907
| -63% | -$86.9M | 0.15% | 167 |
|
|
2022
Q3 | $124M | Buy |
1,183,372
+1,049,159
| +782% | +$115M | 0.38% | 32 |
|
|
2022
Q2 | $14.1M | Sell |
134,213
-276,951
| -67% | -$32.9M | 0.05% | 534 |
|
|
2022
Q1 | $52.6M | Buy |
411,164
+319,748
| +350% | +$38.5M | 0.17% | 131 |
|
|
2021
Q4 | $11.3M | Buy |
+91,416
| New | +$12M | 0.04% | 604 |
|
|
2021
Q2 | – | Sell |
-240,538
| Closed | -$37.4M | – | 2430 |
|
|
2021
Q1 | $37.4M | Sell |
240,538
-12,288
| -5% | -$1.9M | 0.18% | 128 |
|
|
2020
Q4 | $37.8M | Buy |
252,826
+12,165
| +5% | +$1.72M | 0.21% | 117 |
|
|
2020
Q3 | $31.8M | Buy |
240,661
+125,023
| +108% | +$16.3M | 0.23% | 106 |
|
|
2020
Q2 | $13.4M | Sell |
115,638
-261,275
| -69% | -$30.1M | 0.12% | 270 |
|
|
2020
Q1 | $37M | Sell |
376,913
-403,356
| -52% | -$52.9M | 0.44% | 43 |
|
|
2019
Q4 | $113M | Buy |
780,269
+333,688
| +75% | +$46.1M | 0.67% | 14 |
|
|
2019
Q3 | $59.5M | Buy |
446,581
+444,003
| +17,223% | +$57.4M | 0.41% | 43 |
|
|
2019
Q2 | $295K | Sell |
2,578
-625,896
| -100% | -$73.3M | ﹤0.01% | 1324 |
|
|
2019
Q1 | $77.9M | Buy |
628,474
+119,841
| +24% | +$13.6M | 0.52% | 29 |
|
|
2018
Q4 | $51.2M | Buy |
508,633
+447,448
| +731% | +$50.3M | 0.37% | 57 |
|
|
2018
Q3 | $7.81M | Buy |
+61,185
| New | +$7.27M | 0.04% | 563 |
|
|
2018
Q1 | – | Sell |
-48,121
| Closed | -$5.64M | – | 2378 |
|
|
2017
Q4 | $5.64M | Sell |
48,121
-408,580
| -89% | -$46.2M | 0.02% | 819 |
|
|
2017
Q3 | $51.9M | Sell |
456,701
-327,600
| -42% | -$37.8M | 0.2% | 124 |
|
|
2017
Q2 | $97.8M | Buy |
784,301
+734,128
| +1,463% | +$87M | 0.4% | 45 |
|
|
2017
Q1 | $5.95M | Sell |
50,173
-465,426
| -90% | -$52.8M | 0.03% | 654 |
|
|
2016
Q4 | $51.7M | Buy |
515,599
+104,621
| +25% | +$11.2M | 0.28% | 87 |
|
|
2016
Q3 | $51.9M | Sell |
410,978
-2,777
| -0.7% | -$343K | 0.3% | 99 |
|
|
2016
Q2 | $48.4M | Buy |
413,755
+258,618
| +167% | +$29.3M | 0.31% | 78 |
|
|
2016
Q1 | $16.1M | Sell |
155,137
-247,238
| -61% | -$23.9M | 0.1% | 290 |
|
|
2015
Q4 | $40.1M | Buy |
+402,375
| New | +$39.4M | 0.28% | 105 |
|
|
2015
Q3 | – | Sell |
-158,337
| Closed | -$16.8M | – | 1420 |
|
|
2015
Q2 | $16.8M | Buy |
158,337
+55,095
| +53% | +$6.1M | 0.1% | 257 |
|
|
2015
Q1 | $11.8M | Sell |
103,242
-113,496
| -52% | -$12.9M | 0.1% | 308 |
|
|
2014
Q4 | $23.9M | Sell |
216,738
-11,937
| -5% | -$1.26M | 0.22% | 130 |
|
|
2014
Q3 | $22.3M | Buy |
228,675
+156,074
| +215% | +$15.4M | 0.17% | 149 |
|
|
2014
Q2 | $7.32M | Buy |
+72,601
| New | +$7.08M | 0.08% | 296 |
|
|
2013
Q4 | – | Sell |
-41,200
| Closed | -$3.29M | – | 660 |
|
|
2013
Q3 | $3.29M | Buy |
+41,200
| New | +$3.24M | 0.04% | 412 |
|
Other funds holding ZBH
VCM
VPM
Balyasny Asset Management's ZBH Position: Q1 2026 in Review
Balyasny Asset Management increased its Zimmer Biomet (ZBH) stake by 12,817% in Q1 2026, buying an estimated $38.7M and bringing the position to 424,578 shares worth $38.4M. The position accounts for 0.05% of the portfolio, ranked #427.
Balyasny Asset Management first reported a position in ZBH in Q3 2013 and has held it in 40 quarters since. The position peaked at $124M in Q3 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Balyasny Asset Management held 424,578 shares of Zimmer Biomet worth $38.4M as of Q1 2026.
- Balyasny Asset Management bought 421,291 Zimmer Biomet shares in Q1 2026, an estimated $38.7M.
- Zimmer Biomet made up 0.05% of Balyasny Asset Management's portfolio in Q1 2026, its #427 holding.
- Balyasny Asset Management first reported a position in Zimmer Biomet in Q3 2013 and has held it in 40 quarters since.
- Balyasny Asset Management's Zimmer Biomet position peaked at $124M in Q3 2022.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.